PFA Outcome of 32nd Annual General Meeting of the Company held on 29th September, 2026

MPS PHARMAA LIMITED (FORMERLY ADVIK LABORATORIES LIMITED) Dated: 01-10-2026 The Manager (Listing), BSE Limited, 01st Floor,P.J.Towers, Dalal Street, Mumbai– 400001 Subject : Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Outcome of the 32nd Annual General Meeting ("AGM") of the Company held on Tuesday, 29th September, 2026 Ref : BSE Scrip Code–531686; ASE Scrip Code-01636 (ADVIKLABO) Dear Sir, Pursuant to the provisions of Regulation 30 read with Schedule III and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations"), we wish to inform you that, based on the Report dated September 30, 2026 submitted by the Scrutinizer, M/s Kundan Agrawal & Associates appointed for the 32nd Annual General Meeting ("AGM"), of the company, all the resolutions as set out in the Notice convening the 32nd AGM have been duly passed by the shareholders of the Company with the requisite majority. Accordingly, the Members of the Company at the 32nd Annual General Meeting ("AGM") held on Tuesday, 29th September, 2026 at 09.30 A.M at its registered office situated at 138, Roz-Ka-Meo Industrial Area, Sohna, Distt. Mewat-122103, Haryana, have considered and approved the following businesses: 1. Adoption of Financial Statements: Adopted the Audited Financial Statements of the company including the Balance Sheet of the Company as at 31st March, 2026 and the Statement of Profit and Loss of the Company for the Financial Year ended 31st March, 2026 together with the Cash Flow Statement & other Annexures thereof and the Report of the Board of Directors and Auditors thereon. 2. Re-appointment of Director liable to retire by rotation: Re-appointed Mr. Ram Niwas Sharma (DIN:08427985), who was liable to retire by rotation and being eligible, offered himself for re-appointment pursuant to the provisions of Section 152 of the Companies Act, 2013, as a Non-Executive Director liable to retire by rotation. 3. Re-appointment of Statutory Auditors: Re-appointed M/s. Nemani Garg Agarwal & Co. (Firm Registration No. 010192N), Chartered Accountants as the Statutory Auditors of the company, to hold the office for a further term of 05 consecutive years, i.e. from the conclusion of the 32nd Annual General Meeting of the company until the conclusion of 37th Annual General Meeting of the Company. 4. Approval of Related Party Transactions: Accorded approval for Related Party Transactions under Section 188 of the Companies Act, 2013 and Regulation 23 of SEBI (LODR) Regulations, 2015. CIN No. :L74899HR1994PLC038300 CorporateOffice:703, Arunachalbuilding19,BarakhambaRoad,ConnaughtPlace,NewDelhi110001 Phones:011-42424884,43571040-45, Fax:011-43571047 Regd.Office&Factory:138. Roz-Ka-Meo IndustrialArea,Sohna-122103(Dist .Mewat),Haryana Phones:0124-2362471Email:info@mpspharmaa.comWebsite:www.mpspharmaa.com MPS PHARMAA LIMITED (FORMERLY ADVIK LABORATORIES LIMITED) 5. Appointment of Independent Director: Appointed Ms. Anchal Goyal (DIN 10751205) as an Independent Director of the Company for a term of 5 consecutive years, i.e. from the conclusion of the 32nd Annual General Meeting of the company until the conclusion of 37th Annual General Meeting of the Company. 6. Approval under Section 185 of the Companies Act, 2013: Accorded approval for the transactions under Section 185 of the Companies Act, 2013 read with Rules made thereunder as amended from time to time. The requisite disclosures/details with respect to the re-appointment of Mr. Ram Niwas Sharma as a Non-Executive Director liable to retire by rotation, appointment of Ms. Anchal Goyal as an Independent Director of the Company and re-appointment of M/s. Nemani Garg Agarwal & Co., Chartered Accountants, as the Statutory Auditors of the Company, as required under Regulation 30 read with Schedule III of the SEBI Listing Regulations and SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 09, 2015, are annexed herewith as Annexure A, Annexure B and Annexure C, respectively. This is for your information and records please. Thanking You. Yours Truly, For MPS Pharmaa Limited (Formerly Known as Advik Laboratories Limited) Pooja Chuni Company Secretary Encl: As Above The Manager(Listing) Ahmedabad Stock Exchange Limited 1st Floor, Kamdhenu Complex Opp.Sahajanand College, Panjara Pole, Ambawadi, Ahmedabad–380015 CIN No. :L74899HR1994PLC038300 CorporateOffice:703, Arunachalbuilding19,BarakhambaRoad,ConnaughtPlace,NewDelhi110001 Phones:011-42424884,43571040-45, Fax:011-43571047 Regd.Office&Factory:138. Roz-Ka-Meo IndustrialArea,Sohna-122103(Dist .Mewat),Haryana Phones:0124-2362471Email:info@mpspharmaa.comWebsite:www.mpspharmaa.com MPS PHARMAA LIMITED (FORMERLY ADVIK LABORATORIES LIMITED) Annexure-A Details as per SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 09. 2015 S.NO. PARTICULARS DETAILS 1. Name Mr. Ram Niwas Sharma 2. Fathers’ Name Mr. Zile Singh Sharma 3. D.O.B 10/05/1972 4. E-mail id ram313ram@yahoo.com 5. Address 474A, Sunaron Wali Gali, Ward No 27, Dev Nagara, Sonipat- 131001, Haryana 6. Disclosure of relationships NIL between directors. 7. Occupation Service 8. Nationality INDIAN 9. DIN 08427985 10. Profile Mr. Ram Niwas Sharma has more than two decades of experience in the corporate sector at various levels including stock broking, marketing and general administration. Considering his vast and rich experience, the Board of Directors of the Company has appointed him as a Non- Executive Director of the Company liable to retire by rotation pursuant to the provisions of Section 152 of the Companies Act, 2013. 11. Date of appointment/ cessation & The shareholders of the Company at the 32nd Annual term of appointment; General Meeting held on 29.09.2026 have re-appointed Mr. Ram Niwas Sharma as a Non Executive Director of the Company, liable to retire by rotation. 12. Reason for change viz. Re-appointment of Mr. Ram Niwas Sharma as a Non- appointment, resignation, removal, Executive Director of the Company liable to retire by rotation death or otherwise; pursuant to the provisions of Section 152 of the Companies Act, 2013. For MPS Pharmaa Limited (Formerly Known as Advik Laboratories Limited) Pooja Chuni Company Secretary CIN No. :L74899HR1994PLC038300 CorporateOffice:703, Arunachalbuilding19,BarakhambaRoad,ConnaughtPlace,NewDelhi110001 Phones:011-42424884,43571040-45, Fax:011-43571047 Regd.Office&Factory:138. Roz-Ka-Meo IndustrialArea,Sohna-122103(Dist .Mewat),Haryana Phones:0124-2362471Email:info@mpspharmaa.comWebsite:www.mpspharmaa.com MPS PHARMAA LIMITED (FORMERLY ADVIK LABORATORIES LIMITED) Annexure-B Details as per SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 09. 2015 S.NO. PARTICULARS DETAILS 1. Name Ms. Anchal Goyal 2. Fathers’ Name Mr. Rakesh Goyal 3. D.O.B 10/03/1986 4. E-mail id rachitgargsr@gmail.com 5. Address 1433/7, Kamal Colony, Jain College Road, Saharanpur Police Station Niryat Nigam,Saharanpur, Uttar Pradesh – 247001 6. Disclosure of relationships NIL between directors. 7. Occupation Service 8. Nationality INDIAN 9. DIN 10751205 10. Profile Ms. Anchal Goyal is a MCA (Master of Computer Applications) Post Graduate from Chaudhary Charan Singh University. She has a rich experience of more than 12 years in various aspects of IT management, viz., E-mail Marketing, Marketing Budget Analysis, Graphic Designing, Presentation Software, Computer Programming, the field of marketing and general administration. 11. Date of appointment/ cessation & The shareholders of the Company at the 32nd Annual term of appointment; General Meeting held on 29.09.2026, have appointed Ms. Anchal Goyal (DIN 10751205) as a Non Executive Independent Director of the Company for a term of 5 consecutive years to hold office from the date of the 32ndAnnual General Meeting up to the date of the 37thAnnual General Meeting of the Company to be held in the Year 2031. 12. Reason for change [Showing first 8,000 characters — download PDF for full document]